Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04381975

Move in Mind: Program for Reducing Musculoskeletal Pain

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
McGill University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The present pilot study will explore the range of mental and physical health benefits associated with a Rolfing®-based intervention program ("Move in Mind"). To assess the effects of this program on pain management and various psychological outcomes, the investigator's study will be offered to individuals with mild chronic musculoskeletal pain (e.g., lower back pain, neck pain, shoulder pain, knee pain, arthritic pain). Shortened from ten to six sessions and adapted to a group setting by Rolfing® instructor Monica Canducci, the intervention will be delivered weekly by Ms. Canducci, who is certified in Rolfing®. The program will target the potential associations of the Move in Mind program with better pain management (primary outcome) as well as increased body awareness and presence, increased well-being, and better stress management (secondary outcomes). Interested participants will be asked to complete a battery of questionnaires and psychometric scales to assess the variables of interest before (baseline) and after their participation in the Move in Mind program (six-week follow-up). A waitlist control group will also be assessed at baseline and follow-up and will then receive the Move in Mind sessions subsequently and also assessed after their participation.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMove in Mind ProgramEach of the six Move in Mind sessions will take place once a week for approximately 1.5 hours, with 12-17 individuals participating per class. The material and exercises taught will include physical floor exercises, breathing exercises, as well as awareness training.
BEHAVIORAL6 Week Waitlist ControlThe waitlist control group will receive the Move in Mind program after 6 weeks.

Timeline

Start date
2024-01-01
Primary completion
2024-12-30
Completion
2024-12-31
First posted
2020-05-11
Last updated
2024-03-15

Source: ClinicalTrials.gov record NCT04381975. Inclusion in this directory is not an endorsement.